Literature DB >> 12525624

A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo.

Shigeru Tajima1, Masahiko Takahashi, Shin-Nosuke Takeshima, Satoru Konnai, Shan Ai Yin, Shinobu Watarai, Yoshimasa Tanaka, Misao Onuma, Kosuke Okada, Yoko Aida.   

Abstract

In a previous study, we identified an interesting mutant form of the Tax protein of bovine leukemia virus (BLV), designated D247G. This mutant protein strongly transactivated the long terminal repeat of BLV and was also able to transactivate the cellular proto-oncogene c-fos. This finding suggested that BLV that encode the mutant protein might propagate and induce lymphoma more efficiently than wild-type BLV. To characterize the effects of the strong transactivation activity of the mutant Tax protein, we constructed an infectious molecular clone of BLV that encoded D247G and examined the replication and propagation of the virus in vitro and in vivo. Cultured cells were transfected with the wild-type and mutant BLV, and then levels of viral proteins and particles and the propagation of viruses were compared. As expected, in vitro, mutant BLV produced more viral proteins and particles and was transmitted very effectively. We injected the wild-type and mutant BLV into sheep, which are easily infected with BLV, and monitored the proportion of BLV-positive cells in the blood and the expression of BLV RNA for 28 weeks. By contrast to the results of our analyses in vitro, we found no significant difference in the viral load or the expression of viral RNA between sheep inoculated with wild-type or mutant BLV. Our observations indicate that the mutant D247G Tax protein does not enhance the expansion of BLV and that there might be a dominant mechanism for regulation of the expression of BLV in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525624      PMCID: PMC140974          DOI: 10.1128/jvi.77.3.1894-1903.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus.

Authors:  D Pyeon; K L O'Reilly; G A Splitter
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma.

Authors:  S Tajima; W Z Zhuang; M V Kato; K Okada; Y Ikawa; Y Aida
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

3.  Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.

Authors:  E R Johnston; M A Powers; L C Kidd; K Radke
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Cellular pathways involved in the ex vivo expression of bovine leukemia virus.

Authors:  P Kerkhofs; E Adam; L Droogmans; D Portetelle; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression.

Authors:  E Adam; P Kerkhofs; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Interaction of bovine leukemia virus transactivator Tax with bZip proteins.

Authors:  I M Boros; F Tie; C Z Giam
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

7.  Involvement of the cyclic AMP-responsive element binding protein in bovine leukemia virus expression in vivo.

Authors:  E Adam; P Kerkhofs; M Mammerickx; R Kettmann; A Burny; L Droogmans; L Willems
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus.

Authors:  K Inabe; K Ikuta; Y Aida
Journal:  Virology       Date:  1998-05-25       Impact factor: 3.616

9.  Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development.

Authors:  S Tajima; Y Ikawa; Y Aida
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Immunopathologic study and characterization of the phenotype of transformed cells in sheep with bovine leukemia virus-induced lymphosarcoma.

Authors:  K Murakami; Y Aida; R Kageyama; S Numakunai; K Ohshima; K Okada; Y Ikawa
Journal:  Am J Vet Res       Date:  1994-01       Impact factor: 1.156

View more
  18 in total

1.  Latency of viral expression in vivo is not related to CpG methylation in the U3 region and part of the R region of the long terminal repeat of bovine leukemia virus.

Authors:  Shigeru Tajima; Masako Tsukamoto; Yoko Aida
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  BLV-CoCoMo-qPCR: a useful tool for evaluating bovine leukemia virus infection status.

Authors:  Mayuko Jimba; Shin-Nosuke Takeshima; Hironobu Murakami; Junko Kohara; Naohiko Kobayashi; Tamako Matsuhashi; Takashi Ohmori; Tetsuo Nunoya; Yoko Aida
Journal:  BMC Vet Res       Date:  2012-09-21       Impact factor: 2.741

3.  Identification of bovine leukemia virus tax function associated with host cell transcription, signaling, stress response and immune response pathway by microarray-based gene expression analysis.

Authors:  Mariluz Arainga; Eri Takeda; Yoko Aida
Journal:  BMC Genomics       Date:  2012-03-28       Impact factor: 3.969

4.  BLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm.

Authors:  Mayuko Jimba; Shin-nosuke Takeshima; Kazuhiro Matoba; Daiji Endoh; Yoko Aida
Journal:  Retrovirology       Date:  2010-11-02       Impact factor: 4.602

5.  Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade.

Authors:  Ryoyo Ikebuchi; Satoru Konnai; Tatsuya Shirai; Yuji Sunden; Shiro Murata; Misao Onuma; Kazuhiko Ohashi
Journal:  Vet Res       Date:  2011-09-26       Impact factor: 3.683

6.  Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-qPCR.

Authors:  Carlos Javier Panei; Shin-nosuke Takeshima; Takashi Omori; Tetsuo Nunoya; William C Davis; Hiroshi Ishizaki; Kazuhiro Matoba; Yoko Aida
Journal:  BMC Vet Res       Date:  2013-05-04       Impact factor: 2.741

7.  A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep.

Authors:  Carole Pomier; Maria Teresa Sanchez Alcaraz; Christophe Debacq; Agnes Lançon; Pierre Kerkhofs; Lucas Willems; Eric Wattel; Franck Mortreux
Journal:  Retrovirology       Date:  2009-04-03       Impact factor: 4.602

Review 8.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

9.  Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.

Authors:  Jerome S Harms; Kurt A Eakle; Lillian S Kuo; Robert D Bremel; Gary A Splitter
Journal:  Genet Vaccines Ther       Date:  2004-08-24

Review 10.  Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus.

Authors:  Yoko Aida; Hironobu Murakami; Masahiko Takahashi; Shin-Nosuke Takeshima
Journal:  Front Microbiol       Date:  2013-11-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.